First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: Wolters Kluwer: the story is balanced — Organic revenue growth rate in Health division (UpToDate subscriber additions, hospital penetration rates)
★ Analysts see FY2027 revenue reaching $6.5B — +5.2% growth in a single year.
What Moves the Stock
1Organic revenue growth rate in Health division (UpToDate subscriber additions, hospital penetration rates)
2Tax software recurring revenue retention and CCH cloud migration progress in North America
3Expert solutions bookings growth and annual contract value expansion in GRC division
4Currency translation impact from EUR/USD movements (50%+ revenue in Europe, reports in EUR but trades as ADR)
5Margin expansion from digital mix shift and operational efficiency programs
6M&A activity in fragmented compliance software markets
7Health division (~40% of revenue): Clinical decision support tools (UpToDate), drug information databases, medical education platforms serving hospitals and physicians
8Tax & Accounting (~25% of revenue): CCH software for tax professionals, audit solutions, accounting workflow automation primarily in North America
value/quality - The 60.5% one-year decline has compressed valuation to 2.3x P/S (likely below historical 3-4x range for quality recurring…
Rising rates create moderate headwinds through three channels: (1) Higher discount rates compress valuation multiples for high-quality…
Watch on earnings: UpToDate institutional subscriber count and per-subscriber revenue trends (bellwether for Health division), CCH Axcess cloud migration percentage and recurring revenue mix in Tax & Accounting, EUR/USD exchange rate (material impact on ADR valuation and reported growth).
One Sentence Summary:
Wolters Kluwer: the story is balanced — organic revenue growth rate in health division (uptodate subscriber additions, hospital penetration rates).
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.